Management of von Willebrand disease with a factor VIII‐poor von Willebrand factor concentrate: Results from a prospective observational post‐marketing study-Reference-Cited by-同舟云学术

Management of von Willebrand disease with a factor VIII‐poor von Willebrand factor concentrate: Results from a prospective observational post‐marketing study

Published:2020-06-25 Issue:8 Volume:18 Page:1922-1933
ISSN:1538-7933
Container-title:Journal of Thrombosis and Haemostasis
language:en
Short-container-title:J Thromb Haemost

Author:

Goudemand Jenny¹,Bridey Françoise²,Claeyssens Ségolène³,Itzhar‐Baïkian Nathalie⁴,Harroche Annie⁵,Desprez Dominique⁶,Négrier Claude⁷,Chamouni Pierre⁸,Chambost Hervé⁹,Henriet Céline²,Susen Sophie¹¹⁰,Borel‐Derlon Annie¹¹

Affiliation:

1. Department of Hemostasis and Transfusion Lille University Hospital Lille France

2. Clinical Development Laboratoire français du Fractionnement et des Biotechnologies (LFB) Les Ulis France

3. Centre de Ressources et Compétences Maladies Hémorragiques ConstitutionnellesCRC MHC URMPurpan Hospital Toulouse France

4. Service d’Hématologie Biologique Hôpital LariboisièreAPHP Paris France

5. Hemophilia Care Center Necker Hospital Paris France

6. Centre de compétences trouble de l’hémostase Hopital de Hautepierre Strasbourg France

7. Hematology Division Hemophilia Comprehensive Care CenterLouis Pradel HospitalUniversity Lyon1 Bron France

8. Hemophilia Care Center Rouen University Hospital Rouen France

9. APHM Centre for Bleeding Disorders La Timone Children Hospital and Aix‐Marseille UniversityINRA InsermMarseille France

10. EGID INSERM Institut Pasteur de Lille University of Lille Lille France

11. Hemophilia Treatment Centre University Hospital of Caen Caen France

Funder

Laboratoire français du Fractionnement et des Biotechnologies

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jth.14928

Reference45 articles.

1. Von Willebrand’s Disease

2. Von Willebrand’s disease in the year 2003: towards the complete identification of gene defects for correct diagnosis and treatment;Castaman G;Haematologica,2003

3. von Willebrand factor: the old, the new and the unknown

4. Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor

5. Epidemiological investigation of the prevalence of von Willebrand's disease

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-World Efficacy and Safety of Plasma-Derived Von Willebrand Factor-Containing Factor VIII Concentrates in Patients With Von Willebrand Disease in Italy;Clinical and Applied Thrombosis/Hemostasis;2024-07-21

2. Knee replacement surgery in a patient with acquired von Willebrand disease: a case study with recommendations for patient management;Annals of Medicine & Surgery;2024-01-08

3. Key Drivers of Coagulation Factor Use in Von Willebrand Disease During Hospitalization: An Overview of the French BERHLINGO Cohort;Clinical Drug Investigation;2023-11-30

4. Von Willebrand Disease Epidemiology, Burden of Illness and Management: A Systematic Review;Journal of Blood Medicine;2023-03

5. Efficacy and safety of von Willebrand factor concentrate almost devoid of factor VIII (Wilfactin^®) in paediatric patients under 6 years of age with severe von Willebrand disease;BLOOD TRANSFUS-ITALY;2023